Crossmark Global Holdings’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $58.6M | Buy |
|
|||||
|
2025
Q2 | $56.9M | Sell |
|
|||||
|
2025
Q1 | $61.9M | Buy |
|
|||||
|
2024
Q4 | $49.9M | Buy |
|
|||||
|
2024
Q3 | $44.6M | Buy |
|
|||||
|
2024
Q2 | $34.1M | Buy |
|
|||||
|
2024
Q1 | $35.6M | Sell |
|
|||||
|
2023
Q4 | $41.5M | Sell |
|
|||||
|
2023
Q3 | $39.2M | Buy |
|
|||||
|
2023
Q2 | $39.4M | Buy |
|
|||||
|
2023
Q1 | $38.9M | Buy |
|
|||||
|
2022
Q4 | $29.9M | Buy |
|
|||||
|
2022
Q3 | $20.5M | Buy |
|
|||||
|
2022
Q2 | $20.3M | Buy |
|
|||||
|
2022
Q1 | $19.1M | Buy |
|
|||||
|
2021
Q4 | $16.7M | Buy |
|
|||||
|
2021
Q3 | $13.7M | Buy |
|
|||||
|
2021
Q2 | $13.5M | Buy |
|
|||||
|
2021
Q1 | $12M | Buy |
|
|||||
|
2020
Q4 | $10.8M | Sell |
|
|||||
|
2020
Q3 | $12M | Sell |
|
|||||
|
2020
Q2 | $15.3M | Sell |
|
|||||
|
2020
Q1 | $15.8M | Sell |
|
|||||
|
2019
Q4 | $14M | Buy |
|
|||||
|
2019
Q3 | $13.4M | Sell |
|
|||||
|
2019
Q2 | $14.6M | Sell |
|
|||||
|
2019
Q1 | $14.2M | Buy |
|
|||||
|
2018
Q4 | $13.3M | Buy |
|
|||||
|
2018
Q3 | $15.7M | Buy |
|
|||||
|
2018
Q2 | $14.4M | Sell |
|
|||||
|
2018
Q1 | $15.3M | Sell |
|
|||||
|
2017
Q4 | $16.2M | Buy |
|
|||||
|
2017
Q3 | $18M | Buy |
|
|||||
|
2016
Q3 | $18M | Buy |
|